Bioactive glass S53P4 eradicates Staphylococcus aureus in biofilm/planktonic states in vitro

References

• Hoiby N. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey. Acta Pathol Microbiol Scand Suppl. 1977;(262):1–96.
   PubMedGoogle Scholar
• DeAntonio R, Yarzabal JP, Cruz JP, Schmidt JE, Kleijnen J. Epidemiology of otitis media in children from developing countries: a systematic review. Int J Pediatr Otorhinolaryngol. 2016;85:65–74. doi:10.1016/j.ijporl.2016.03.032
   PubMed Web of Science ®Google Scholar
• Percival SL, Hill KE, Williams DW, Hooper SJ, Thomas DW, Costerton JW. A review of the scientific evidence for biofilms in wounds. Wound Repair Regen. 2012;20:647–57. doi:10.1111/j.1524-475X.2012.00836.x
   PubMed Web of Science ®Google Scholar
• Burmølle M, Thomsen TR, Fazli M, Dige I, Christensen L, Homøe P, et al. Biofilms in chronic infections – a matter of opportunity – monospecies biofilms in multispecies infections. FEMS Immunol Med Microbiol. 2010;59:324–36. doi:10.1111/j.1574-695X.2010.00714.x
   PubMed Web of Science ®Google Scholar
• Lampikoski H, Aarnisalo AA, Jero J, Kinnari TJ. Mastoid biofilm in chronic otitis media. Otol Neurotol. 2012;33:785–8. doi:10.1097/MAO.0b013e318259533f
   PubMed Web of Science ®Google Scholar
• Nason R, Chole RA. Bacterial biofilms may explain chronicity in osteoradionecrosis of the temporal bone. Otol Neurotol. 2007;28:1026–8. doi:10.1097/MAO.0b013e318157f102
   PubMed Web of Science ®Google Scholar
• Lewis K. Persister cells. Annu Rev Microbiol. 2010;64:357–72. doi:10.1146/annurev.micro.112408.134306
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell Microbiol. 2009;11:1034–43. doi:10.1111/j.1462-5822.2009.01323.x
   PubMed Web of Science ®Google Scholar
• Nickel JC, Ruseska I, Wright JB, Costerton JW. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother. 1985;27:619–24. doi:10.1128/aac.27.4.619
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2:95–108. doi:10.1038/nrmicro821
   PubMed Web of Science ®Google Scholar
• Singh R, Ray P, Das A, Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J Antimicrob Chemother. 2010;65:1955–8. doi:10.1093/jac/dkq257
   PubMed Web of Science ®Google Scholar
• Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Lappin-Scott HM. Microbial biofilms. Annu Rev Microbiol. 1995;49:711–45. doi:10.1146/annurev.mi.49.100195.003431
   PubMed Web of Science ®Google Scholar
• Liñares J, Ardanuy C, Pallares R, Fenoll A. Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period. Clin Microbiol Infect. 2010;16:402–10. doi:10.1111/j.1469-0691.2010.03182.x
   PubMed Web of Science ®Google Scholar
• Moxnes JF, de Blasio BF, Leegaard TM, Moen AE. Methicillin-resistant Staphylococcus aureus (MRSA) is increasing in Norway: a time series analysis of reported MRSA and methicillin-sensitive S. aureus cases, 1997-2010. PLoS One. 2013;8:e70499. doi:10.1371/journal.pone.0070499
   PubMedGoogle Scholar
• Drago L, Toscano M, Bottagisio M. Recent evidence on bioactive glass antimicrobial and antibiofilm activity: a mini-review. Materials 2018;11:326. doi:10.3390/ma11020326
   Web of Science ®Google Scholar
• Coraca-Huber DC, Fille M, Hausdorfer J, Putzer D, Nogler M. Efficacy of antibacterial bioactive glass S53P4 against S. aureus biofilms grown on titanium discs in vitro. J Orthop Res. 2014;32:175–7. doi:10.1002/jor.22463
   PubMed Web of Science ®Google Scholar
• van Gestel NA, Geurts J, Hulsen DJ, van Rietbergen B, Hofmann S, Arts JJ. Clinical applications of S53P4 bioactive glass in bone healing and osteomyelitic treatment: a literature review. Biomed Res Int. 2015;2015:684826. doi:10.1155/2015/684826
   PubMed Web of Science ®Google Scholar
• Baino F, Hamzehlou S, Kargozar S. Bioactive glasses: where are we and where are we going? JFB. 2018;9:25. doi:10.3390/jfb9010025
   Google Scholar
• Kluge A, Neudert M, Kunert-Keil C, Lailach S, Zahnert T, Kemper M. The obliteration of noncritical size bone defects with bone dust or bone replacement material (bioactive glass S53P4). Otol Neurotol. 2019;40:e415–23. doi:10.1097/MAO.0000000000002178
   PubMed Web of Science ®Google Scholar
• Lindfors NC, Hyvönen P, Nyyssönen M, Kirjavainen M, Kankare J, Gullichsen E, et al. Bioactive glass S53P4 as bone graft substitute in treatment of osteomyelitis. Bone 2010;47:212–8. doi:10.1016/j.bone.2010.05.030
   PubMed Web of Science ®Google Scholar
• Peltola M, Aitasalo K, Suonpää J, Varpula M, Yli-Urpo A. Bioactive glass S53P4 in frontal sinus obliteration: a long-term clinical experience. Head Neck. 2006;28:834–41. doi:10.1002/hed.20436
   PubMed Web of Science ®Google Scholar
• Sarin J, Grenman R, Aitasalo K, Pulkkinen J. Bioactive glass S53P4 in mastoid obliteration surgery for chronic otitis media and cerebrospinal fluid leakage. Ann Otol Rhinol Laryngol. 2012;121:563–9. doi:10.1177/000348941212100901
   PubMed Web of Science ®Google Scholar
• Silvola JT. Mastoidectomy cavity obliteration with bioactive glass: a pilot study. Otolaryngol Head Neck Surg. 2012;147:119–26. doi:10.1177/0194599812438168
   PubMed Web of Science ®Google Scholar
• Hakanen A, Huovinen P, Kotilainen P, Siitonen A, Jousimies-Somer H. Quality control strains used in susceptibility testing of Campylobacter spp. J Clin Microbiol. 2002;40:2705–6. doi:10.1128/jcm.40.7.2705-2706.2002
   PubMed Web of Science ®Google Scholar
• Masadeh MM, Mhaidat NM, Alzoubi KH, Hussein EI, Al-Trad EI. In vitro determination of the antibiotic susceptibility of biofilm-forming Pseudomonas aeruginosa and Staphylococcus aureus: possible role of proteolytic activity and membrane lipopolysaccharide. Infect Drug Resist. 2013;6:27–32. doi:10.2147/IDR.S41501
   PubMedGoogle Scholar
• Munukka E, Leppäranta O, Korkeamäki M, Vaahtio M, Peltola T, Zhang D, et al. Bactericidal effects of bioactive glasses on clinically important aerobic bacteria. J Mater Sci Mater Med. 2008;19:27–32. doi:10.1007/s10856-007-3143-1
   PubMed Web of Science ®Google Scholar
• Massias L, Buffe P, Cohen B, Cudennec Y, Gehanno P, Sterkers O, et al. Study of the distribution of oral ciprofloxacin into the mucosa of the middle ear and the cortical bone of the mastoid process. Chemotherapy 1994;40:3–7. doi:10.1159/000239309
   PubMed Web of Science ®Google Scholar
• Wiegand I, Hilpert K, Hancock RE. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances. Nat Protoc. 2008;3:163–75. doi:10.1038/nprot.2007.521
   PubMed Web of Science ®Google Scholar
• Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S, Cirković I, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. Apmis. 2007;115:891–9. doi:10.1111/j.1600-0463.2007.apm_630.x
   PubMed Web of Science ®Google Scholar
• Moussa SH, Tayel AA, Al-Hassan AA, Farouk A. Tetrazolium/formazan test as an efficient method to determine fungal chitosan antimicrobial activity. J Mycol. 2013;2013:1–7. doi:10.1155/2013/753692
   Google Scholar
• Tengerdy RP, Nagy JG, Martin B. Quantitative measurement of bacterial growth by the reduction of tetrazolium salts. Appl Microbiol. 1967;15:954–5.
   PubMedGoogle Scholar
• Pérez LM, Alvarez BL, Codony F, Fittipaldi M, Adrados B, Peñuela G, et al. A new microtitre plate screening method for evaluating the viability of aerobic respiring bacteria in high surface biofilms. Lett Appl Microbiol. 2010;51:331–7. doi:10.1111/j.1472-765X.2010.02902.x
   PubMed Web of Science ®Google Scholar
• Junka A, Bartoszewicz M, Smutnicka D, Secewicz A, Szymczyk P. Efficacy of antiseptics containing povidone-iodine, octenidine dihydrochloride and ethacridine lactate against biofilm formed by Pseudomonas aeruginosa and Staphylococcus aureus measured with the novel biofilm-oriented antiseptics test. Int Wound J. 2014;11:730–4. doi:10.1111/iwj.12057
   PubMed Web of Science ®Google Scholar
• Grønseth T, Vestby LK, Nesse LL, Thoen E, Habimana O, von Unge M, et al. Lugol’s solution eradicates Staphylococcus aureus biofilm in vitro. Int J Pediatr Otorhinolaryngol. 2017;103:58–64. doi:10.1016/j.ijporl.2017.09.025
   PubMed Web of Science ®Google Scholar
• Mah TF. Establishing the minimal bactericidal concentration of an antimicrobial agent for planktonic cells (MBC-P) and biofilm cells (MBC-B). J Vis Exp 2014;(83):e50854. doi:10.3791/50854
   PubMed Web of Science ®Google Scholar
• Zenga J, Gagnon PM, Vogel J, Chole RA. Biofilm formation by otopathogenic strains of Pseudomonas aeruginosa is not consistently inhibited by ethylenediaminetetraacetic acid. Otol Neurotol. 2012;33:1007–12. doi:10.1097/MAO.0b013e31825f249e
   PubMed Web of Science ®Google Scholar
• Wang EW, Agostini G, Olomu O, Runco D, Jung JY, Chole RA. Gentian violet and ferric ammonium citrate disrupt Pseudomonas aeruginosa biofilms. Laryngoscope. 2008;118:2050–6. doi:10.1097/MLG.0b013e3181826e24
   PubMed Web of Science ®Google Scholar
• Araújo PA, Mergulhão F, Melo L, Simões M. The ability of an antimicrobial agent to penetrate a biofilm is not correlated with its killing or removal efficiency. Biofouling 2014;30:675–83. doi:10.1080/08927014.2014.904294
   PubMed Web of Science ®Google Scholar
• Stoor P, Söderling E, Salonen JI. Antibacterial effects of a bioactive glass paste on oral microorganisms. Acta Odontol Scand. 1998;56:161–5. doi:10.1080/000163598422901
   PubMed Web of Science ®Google Scholar
• Smolka LR, Nelson FE, Kelley LM. Interaction of pH and NaCl on enumeration of heat-stressed Staphylococcus aureus. Appl Microbiol. 1974;27:443–7.
   PubMedGoogle Scholar
• Genigeorgis C, Foda MS, Mantis A, Sadler WW. Effect of sodium chloride and pH on enterotoxin C production. Appl Microbiol. 1971;21:862–6.
   PubMedGoogle Scholar
• Allan I, Newman H, Wilson M. Particulate Bioglass reduces the viability of bacterial biofilms formed on its surface in an in vitro model. Clin Oral Implants Res. 2002;13:53–8. doi:10.1034/j.1600-0501.2002.130106.x
   PubMed Web of Science ®Google Scholar
• Anderson KL, Roux CM, Olson MW, Luong TT, Lee CY, Olson R, et al. Characterizing the effects of inorganic acid and alkaline shock on the Staphylococcus aureus transcriptome and messenger RNA turnover. FEMS Immunol Med Microbiol. 2010;60:208–50. doi:10.1111/j.1574-695X.2010.00736.x
   PubMedGoogle Scholar
• Romanò CL, Logoluso N, Meani E, Romanò D, De Vecchi E, Vassena C, et al. A comparative study of the use of bioactive glass S53P4 and antibiotic-loaded calcium-based bone substitutes in the treatment of chronic osteomyelitis: a retrospective comparative study. Bone Joint J. 2014;96-B:845–50. doi:10.1302/0301-620X.96B6.33014
   PubMedGoogle Scholar